NEW YORK (GenomeWeb) – Meridian Bioscience today announced it has obtained CE marking for two molecular assays for detecting herpes simplex virus type 1 and type 2. 

The company has launched the assays in Europe. They run on Meridian Bio's Illumigene platform and use cutaneous and mucocutaneous specimens from symptomatic patients for the qualitative detection and differentiation of HSV-1 and HSV-2 with results generated within one hour. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.